Dudediligence.

Immix Biopharma, Inc

IMMXNASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 308-KOther events8.019.01
  2. Sep 29424B5Prospectus for an offering
  3. Sep 298-KRegulation FD disclosure and other events7.018.019.01
  4. Aug 1413GPassive stake of 5% or more (13G), filed by Eventide Asset Management
  5. Aug 710-QQuarterly report
  6. Jul 208-KOther events8.01
  7. May 298-KShareholder vote5.07
  8. May 218-KOther events8.019.01
  9. May 21424B5Prospectus for an offering
  10. May 218-KRegulation FD disclosure and other events7.018.019.01
  11. May 710-QQuarterly report
  12. Mar 308-KRegulation FD disclosure and other events7.018.019.01
  13. Mar 258-KMaterial agreement1.019.01
  14. Mar 25424B5Prospectus for an offering
  15. Mar 2510-KAnnual report
  16. Jan 9S-3Shelf registration
  17. Dec 8, 20258-KMaterial agreement1.019.01
  18. Dec 8, 2025424B5Prospectus for an offering
  19. Dec 8, 20258-KRegulation FD disclosure and other events7.018.019.01
  20. Nov 26, 20258-KOther events8.019.01
  21. Nov 7, 202510-QQuarterly report
  22. Oct 6, 2025S-3Shelf registration
  23. Sep 8, 20258-KMaterial agreement and unregistered sale of shares1.013.025.029.01
  24. Aug 8, 202510-QQuarterly report
  25. Jun 23, 20258-KShareholder vote5.07
  26. Jun 3, 2025424B5Prospectus for an offering
  27. Jun 3, 20258-KMaterial agreement1.019.01
  28. May 8, 202510-QQuarterly report
  29. Mar 24, 202510-KAnnual report
  30. Nov 12, 202410-QQuarterly report